Article
Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
Molecular genetics and metabolism - 1 Aug 2012
Heintz Caroline, Dobrowolski Steven F, Andersen Henriette Skovgaard, Demirkol Mübeccel, Blau Nenad, Andresen Brage Storstein
Abstract excerpt
In about 20-30% of phenylketonuria (PKU) patients, phenylalanine (Phe) levels can be controlled by cofactor 6R-tetrahydrobiopterin (BH(4)) administration. The phenylalanine hydroxylase (PAH) genotype has a predictive value concerning BH(4)-response and therefore a correct assessment of the mutation molecular pathology is important. Mutations that disturb the splicing of exons (e.g. interplay between splice site...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
